Roche News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

27.06.23	Roche receives FDA clearance for additional Alzheimer's disease Cerebrospinal Fluid (CSF) assays, supporting timely diagnosis and treatment decision-making (PR Newswire)
16.06.23	FDA Oks Roche's Columvi To Treat Adult With Relapsed Or Refractory Diffuse Large B-cell Lymphoma (RTTNews)
13.06.23	Roche Granted WHO Prequalification For The Cobas HPV Test (RTTNews)
17.05.23	Genentech Reports Positive Trial Results For Fenebrutinib In Relapsing Forms Of Multiple Sclerosis (RTTNews)
17.05.23	Roche showcases commitment to advancing innovative diagnostic solutions at WorldLab-EuroMedLab (PR Newswire)
09.05.23	FDA Accepts SBLA For Genentech's Vabysmo For Retinal Vein Occlusion Treatment (RTTNews)
08.05.23	SD Biosensor Recalls Certain COVID-19 At-Home Tests Distributed By Roche (RTTNews)
26.04.23	Roche Q1 Group Sales Down 3% At CER; Confirms 2023 Outlook (RTTNews)
17.04.23	Genentech : Tecentriq Combination Reduces Risk Of Cancer Returning In People With Liver Cancer (RTTNews)
13.04.23	Genentech : Vabysmo Data Suggest Rapid Drying Of Retinal Fluid In Patients With Wet AMD And DME (RTTNews)
11.04.23	Roche Introduces Digital Library Of Medical Algorithms 'navify Algorithm Suite' (RTTNews)
11.04.23	Roche introduces navify® Algorithm Suite, a digital library of medical algorithms that enhances clinical decision-making to optimise patient care (PR Newswire)
31.03.23	Biotech Stocks Facing FDA Decision In April 2023 (RTTNews)
30.03.23	Omega Enters Supply Agreement With Roche To Evaluate OTX-2002 In Combination With Atezolizumab (RTTNews)
29.03.23	Astellas, Roche To Develop Integrated Diabetes Self-management Solution With BlueStar (RTTNews)
22.03.23	Roche, Lilly To Develop Elecsys Amyloid Plasma Panel To Boost Early Diagnosis Of Alzheimer's Disease (RTTNews)
20.03.23	Roche : New Data For Evrysdi Reinforce Long-Term Efficacy And Safety Profile In Types 2 And 3 SMA (RTTNews)
10.03.23	FDA Panel Backs Genentech' Polivy Combination For Untreated Diffuse Large B-Cell Lymphoma (RTTNews)
06.03.23	Roche Announces FDA Approval Of Label Expansion For VENTANA PD-L1 Assay (RTTNews)
06.03.23	Roche receives FDA approval of label expansion for VENTANA PD-L1 (SP263) Assay to identify patients with locally advanced and metastatic non-small cell lung cancer eligible for Libtayo (PR Newswire)
28.02.23	Biotech Stocks Facing FDA Decision In March 2023 (RTTNews)
28.02.23	Roche Collaborates With CDC To Strengthen Laboratory Capabilities In Countries Affected By HIV & TB (RTTNews)
28.02.23	Roche joins forces with the U.S. Centers for Disease Control and Prevention to strengthen laboratory systems in the fight against the HIV and tuberculosis epidemics (PR Newswire)
10.02.23	Genentech : Phase III Data Show Vabysmo Improves Vision And Reduced Retinal Fluid In RVO (RTTNews)
09.02.23	Roche expands collaboration with Janssen to advance personalised healthcare through companion diagnostics (PR Newswire)
07.02.23	Roche Announces Positive Results From Phase III Study Of Crovalimab In PNH (RTTNews)
01.02.23	EC Approves Label Expansion Of Roche' Hemlibra To Include People With Moderate Haemophilia A (RTTNews)
30.01.23	Jana Care to Enter Collaboration with Roche to Develop and Distribute Blood Testing Platform to Improve Remote Care for Patients With Chronic Kidney and Heart Disease (PR Newswire)
20.01.23	Seagen : FDA Grants Accelerated Approval To Tukysa Combination For Colorectal Cancer Treatment (RTTNews)
19.01.23	Roche : Phase III Study Of Tecentriq Combination In Hepatocellular Carcinoma Meets Primary Endpoint (RTTNews)
12.01.23	Roche: European Commission Approves Xofluza For Children Aged One Year And Above (RTTNews)
06.01.23	FDA Grants Priority Review To Genentech's Glofitamab To Treat R/R Large B-cell Lymphoma (RTTNews)
23.12.22	FDA Approves Genentech's Lunsumio To Treat Relapsed Or Refractory Follicular Lymphoma (RTTNews)
22.12.22	FDA Okays Roche's Actemra For Treatment Of COVID-19 In Hospitalized Adults (RTTNews)
16.12.22	Roche's Hemlibra Gets Positive CHMP Opinion For Label Expansion (RTTNews)
15.12.22	New Survey Shows Many Americans Are Confused by Testing Options for COVID-19 and Flu (PR Newswire)
14.12.22	Roche Collaborates With Pfizer To Educate On Importance Of Timely COVID-19 Testing (RTTNews)
08.12.22	Roche Announces FDA Clearance For Its Elecsys Alzheimer's Disease CSF Assays (RTTNews)
05.12.22	Roche Announces Brad Moore as President and CEO of Roche Diagnostics North America (PR Newswire)
28.11.22	Sarepta: FDA To Review BLA For SRP-9001 - Quick Facts (RTTNews)
28.11.22	Biotech Stocks Facing FDA Decision In December 2022 (RTTNews)
16.11.22	Roche Receives FDA Emergency Use Authorization For Its Test To Detect Monkeypox Virus (RTTNews)
15.11.22	Roche In Drug Discovery Deal With Jnana Therapeutics (RTTNews)
15.11.22	Jnana Therapeutics Announces Second Collaboration with Roche to Address Challenging-to-Drug Targets in Cancer, Immune-Mediated and Neurological Diseases (PR Newswire)
15.11.22	Roche : FDA Okays VENTANA FOLR1 RxDx Assay To Identify Ovarian Cancer Patients Eligible For ELAHERE (RTTNews)
15.11.22	Roche receives FDA approval for VENTANA FOLR1 (FOLR1-2.1) RxDx Assay as the first IHC-based companion diagnostic to identify ovarian cancer patients eligible for ELAHERE (PR Newswire)
14.11.22	Genentech : Phase III Studies Of Gantenerumab In Early Alzheimer's Disease Fails To Meet Main Goal (RTTNews)
10.11.22	Roche launches Pilot brand, expands retail channels for COVID-19 At-Home Test (PR Newswire)
04.11.22	Roche introduces the navify brand for its digital health solutions at HLTH 2022 (PR Newswire)
27.10.22	Genentech Reports Positive Topline Results From Vabysmo Trial In Retinal Vein Occlusion (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

03.04.25		Roche-Aktie schwächelt: Roche treibt Krebsdiagnostik voran - Forschungsrückschlag mit Ocrevus
05.02.25		Roche punktet bei der FDA: Grünes Licht für Susvimo gegen diabetesbedingte Erblindung - Aktie in Grün
25.06.24		Roche kann EU-Zulassung für Multiple-Sklerose-Mittel an Land ziehen - Aktie sinkt dennoch
10.06.24		Roche-Aktie dennoch tiefer: EU-Kommission lässt Lungenkrebsmedikament Alecensa zu
21.05.24		Roche-Aktie schwächer: Roche-Übernahme von LumiraDx in prüfung - Inavolisib erhält "Breakthrough Therapy"-Status
11.12.23		Roche-Aktie etwas fester: Roche legt Studiendaten zu Kadcyla, Hemlibra, Columvi und Lunsumio vor
02.02.23		Roche-Aktie schwächer: Roche erreicht 2022 Prognose - Umsatz- und Gewinnrückgang im neuen Jahr erwartet
27.12.22		Roche-Aktie leichter: FDA lässt Roches Lymphom-Behandlung Lunsumio zu

03.04.25

Roche-Aktie schwächelt: Roche treibt Krebsdiagnostik voran - Forschungsrückschlag mit Ocrevus

05.02.25

Roche punktet bei der FDA: Grünes Licht für Susvimo gegen diabetesbedingte Erblindung - Aktie in Grün

25.06.24

Roche kann EU-Zulassung für Multiple-Sklerose-Mittel an Land ziehen - Aktie sinkt dennoch

10.06.24

Roche-Aktie dennoch tiefer: EU-Kommission lässt Lungenkrebsmedikament Alecensa zu

21.05.24

Roche-Aktie schwächer: Roche-Übernahme von LumiraDx in prüfung - Inavolisib erhält "Breakthrough Therapy"-Status

11.12.23

Roche-Aktie etwas fester: Roche legt Studiendaten zu Kadcyla, Hemlibra, Columvi und Lunsumio vor

02.02.23

Roche-Aktie schwächer: Roche erreicht 2022 Prognose - Umsatz- und Gewinnrückgang im neuen Jahr erwartet

27.12.22

Roche-Aktie leichter: FDA lässt Roches Lymphom-Behandlung Lunsumio zu

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Sonova Hldg	262.10	3.39 %	K V
Lonza Grp	584.80	2.38 %	K V
Logitech Intl	66.76	1.71 %	K V
Part Grp Hldg	1’114.00	1.41 %	K V
Swisscom	544.00	0.74 %	K V
ABB	45.07	0.04 %	K V
Novartis	90.91	-0.22 %	K V
Zurich Insur Gr	581.00	-0.34 %	K V
Roche Hldg G	257.60	-0.88 %	K V
Kuehne+Nagel Int	177.85	-3.24 %	K V

Roche Aktie VALOR 224184 / ISIN US7711951043

Nachrichten zu Roche Holding AG Sponsored American Deposit Receipt Repr 1/2 NVTGSh

Aktien Top/Flop

Roche Peer Group Nachrichten

Meistgelesene Nachrichten